Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
about
Stroke prevention in diabetes and obesityDronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutterThe burden of atrial fibrillation: should we abandon antiarrhythmic drug therapy?Nonlinear and Stochastic Dynamics in the HeartA review of the pharmacokinetics, electrophysiology and clinical efficacy of dronedarone.Chaos in the genesis and maintenance of cardiac arrhythmias.Atrial fibrillation in heart failure: prognostic significance and management.Managing atrial fibrillation in the elderly: critical appraisal of dronedaroneEnhanced sensitivity of aged fibrotic hearts to angiotensin II- and hypokalemia-induced early afterdepolarization-mediated ventricular arrhythmias.Treating atrial fibrillation. What is the consensus now?Dynamics and cardiac arrhythmias.New antiarrhythmic treatment of atrial fibrillation.Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidineNORMAL QUALITY OF LIFE AFTER THE COX MAZE PROCEDURE FOR ATRIAL FIBRILLATION.Atrial Fibrillation at an Internal Medicine Ward: Clinical and Prognostic Implications.Role of Bi-Atrial Pacing In Slowing The Progression of Paroxysmal Atrial Fibrillation To Permanent Atrial Fibrillation.Future directions in antiarrhythmic drug therapy for atrial fibrillation.Efficacy and safety of dronedarone: a review of randomized trials.Optimizing the management of atrial fibrillation: focus on current guidelines and the impact of new agents on future recommendations.Dronedarone: a new antiarrhythmic agent.A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes.Sinus rhythm restoration and treatment success: insight from recent clinical trials.Update on the clinical management of atrial fibrillation: guidelines and beyond.Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.Safety of flecainide.New approaches to managing nonvalvular atrial fibrillation: what are the thromboembolic implications?Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis.Post-ATHENA and beyond.Trends in the outpatient treatment of atrial fibrillation in the USA from 2001 to 2010.Coronary artery disease potentiates response to dofetilide for rhythm control of atrial fibrillation.Effect of amiodarone dose on the risk of permanent pacemaker insertion.Pharmacologic Conversion during Dofetilide Treatment for Persistent Atrial Fibrillation.Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure.Atrial fibrillation ablation in the era of cryoballoon and force-sensing catheters: freeze or burn?Strategies for atrial fibrillation therapy: focusing onIKurpotassium channel
P2860
Q28200179-9485556E-7A4E-4C01-B72A-7B92E52BAF15Q28295175-E25AFF4E-D39D-4E26-9583-33BA02B61B4AQ30350063-369329C7-E9B4-4F04-B330-ED1BCFFC9AD9Q34245774-9100D858-7406-483A-9810-F1446BA4EDFBQ34612472-A374F830-1ADB-4EDB-B94E-68EFCC7772D3Q34618882-2C2571D6-CEC4-4322-8422-5A4251EE67C9Q35684055-BB1E9FE0-7F2B-4160-BE23-5D687FEC919DQ35702394-C584EB7D-B6C9-4AB5-BB8B-C3280568BC12Q36042700-4741758A-C4C9-4ABD-9DD9-6DBD33290B4AQ36316479-1650EDE2-8845-41DD-98FF-6B55C56F727AQ36561150-C191FCFE-FC91-4E11-ACBA-C18C2056542BQ36867290-4F66D310-166C-4CAA-87F8-CE4EF1A77939Q37159534-411E9B0E-86BC-4FE4-BDB6-F5E2824015F6Q37357740-E733A1D7-9291-4FCF-8053-3DDE0C8B0585Q37495827-5F898732-D1C3-42E8-A1E4-1848415E6EE4Q37496020-BAAFB45B-21E7-4561-AE52-1AF379A0AB4FQ37608547-18264DE8-4965-48C0-A790-B2336DB1E61FQ37650575-E73CEC02-E438-4474-9FB9-729C1E2D8620Q37766393-E8DF8C53-28C0-4C74-910B-2ED6ED511401Q37783295-5D72FD3F-1ED6-407C-8D98-7A61FAC7DE1CQ37811683-FDBE385C-00DF-4F97-AFEA-12B64FF11502Q37812344-5B2D6CA7-B621-496B-B94A-D9B83400FA10Q37831854-FA83C7B7-371F-485F-9ACE-3EB487B0BA71Q37959147-521761D9-D663-4F44-8889-70CDF24F65BAQ37993754-0F4B20D4-4387-401A-8AB4-04F505449CBDQ37995638-00C81EF7-F519-49A8-934D-37F5330AE61FQ38343151-45DE2BA6-EEF5-447F-B9F9-7E690A667754Q38510915-4B536A6F-C6EE-4370-8331-A8BF0903F9DCQ38548311-A263D237-A66A-40E4-9063-5CEA353C5303Q39780721-35882E23-EB3C-454D-ABAB-1D2337DDAEE0Q43856096-C966C535-840D-4D45-A4CF-50500885B956Q44085066-A7F31DED-3DC5-4BFD-B858-1A621B6AC5A8Q45152243-1A6CFB74-A5DF-4A2B-9503-D63FD11BCF66Q48825744-9EAC65FE-BA20-4785-8B9F-F0521EB5B957Q50077869-CE4F90C4-1042-4538-B0C9-B485EA6AE448Q53571955-DA0D2944-D312-4EF0-AB88-AC6DE9413226Q58860331-C5098B88-0DD1-4241-8B14-1320D98C684B
P2860
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Old and new antiarrhythmic dru ...... fficacy and results of trials.
@ast
Old and new antiarrhythmic dru ...... fficacy and results of trials.
@en
type
label
Old and new antiarrhythmic dru ...... fficacy and results of trials.
@ast
Old and new antiarrhythmic dru ...... fficacy and results of trials.
@en
prefLabel
Old and new antiarrhythmic dru ...... fficacy and results of trials.
@ast
Old and new antiarrhythmic dru ...... fficacy and results of trials.
@en
P2093
P1476
Old and new antiarrhythmic dru ...... fficacy and results of trials.
@en
P2093
Deborah L Wolbrette
Gerald V Naccarelli
Jerry Luck
John Hynes
Luna Bhatta
Mazhar Khan
Soraya Samii
P304
P356
10.1016/S0002-9149(02)03375-1
P407
P577
2003-03-01T00:00:00Z